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Summary
Chondrocytes and osteoblasts are two primary cell
types in the skeletal system that are differentiated
from common mesenchymal progenitors. It is be-
lieved that osteoblast differentiation is controlled by
distinct mechanisms in intramembranous and en-
dochondral ossification. We have found that ectopic
canonical Wnt signaling leads to enhanced ossifica-
tion and suppression of chondrocyte formation. Con-
versely, genetic inactivation of b-catenin, an essential
component transducing the canonical Wnt signaling,
causes ectopic formation of chondrocytes at the
expense of osteoblast differentiation during both in-
tramembranous and endochondral ossification. More-
over, inactivation of b-catenin in mesenchymal progeni-
tor cells in vitro causes chondrocyte differentiation
under conditions allowing only osteoblasts to form.
Our results demonstrate that -catenin is essential in
determining whether mesenchymal progenitors will
become osteoblasts or chondrocytes regardless of
regional locations or ossification mechanisms. Con-
trolling Wnt/-catenin signaling is a common molecular
mechanism underlying chondrocyte and osteoblast dif-
ferentiation and specification of intramembranous and
endochondral ossification.
Introduction
Bone and cartilage are major tissues in the vertebrate
skeletal system, which is primarily composed of three
cell types: osteoblasts, chondrocytes, and osteoclasts.
In the developing embryo, osteoblasts and chondro-
cytes both differentiate from common mesenchymal
progenitors in situ, whereas osteoclasts are of hemato-
poietic origin and brought in later by invading blood
vessels. Osteoblast differentiation and maturation lead
to bone formation controlled by two distinct mecha-
nisms: intramembranous and endochondral ossifica-
tion, both starting from mesenchymal condensations
(reviewed by Zelzer and Olsen, 2003; Karsenty and
Wagner, 2002; Yang and Karsenty, 2002). In the former
case, osteoblasts differentiate directly from condensed
mesenchymal precursors, many of which are of the
neural crest cell lineage. This process occurs mostly in
the head region. In the latter case, condensed mes-
enchymal cells give rise to both chondrocytes and os-
teoblasts. Chondrocytes differentiate first and form the*Correspondence: yyang@nhgri.nih.gov
1These authors contributed equally to this work.cartilage template of the future bone while osteoblasts
differentiate and mature in the periphery of the cartilage
(perichondrium) to form bone collars. Chondrocyte
maturation is required for endochondral ossification.
This process happens in most parts of the body includ-
ing the axial and appendicular skeletal elements, which
are formed from the somatic and lateral plate mes-
oderm.
Sox9, a HMG box transcription factor, is required for
chondrocyte cell fate determination and marks early
chondrogenic differentiation of mesenchymal progeni-
tors. Inactivation of Sox9 before mesenchymal conden-
sation abolished not only cartilage formation, but also
endochondral bone formation, which occurs later (Aki-
yama et al., 2002; Bi et al., 1999). Runx2 is a transcrip-
tion factor with Runt domain required for osteoblast cell
fate determination (Ducy et al., 1997; Komori et al.,
1997; Otto et al., 1997) and marks early osteoblast dif-
ferentiation. Progenitor cells in early mesenchymal con-
densations have dual differentiation potentials as they
coexpress Sox9 and Runx2 (Yamashiro et al., 2004;
Ducy et al., 1997; Otto et al., 1997; Bi et al., 1999).
Moreover, it has been shown that in vitro cultured em-
bryonic calvarial cells, which are destined for intra-
membranous bone formation in vivo, can form chon-
drocytes under certain conditions (Fang and Hall, 1997;
Toma et al., 1997; Wong and Tuan, 1995), suggesting
that chondrogenic potential of the osteochondral pro-
genitor cells may be actively suppressed in vivo during
intramembranous ossification. Thus, a critical step in
vertebrate skeletal development is the proper differenti-
ation of osteoblasts or chondrocytes from osteochon-
dral mesenchymal progenitors.
It appears that there is a competition or mutual sup-
pression between the genetic pathways that lead to
either osteoblast or chondrocyte differentiation in the
common mesenchymal progenitors during both endo-
chondral and intramembranous ossification. Inactivation
of Sox9 in the head region in neural crest cell-derived
mesenchyme blocks chondrocyte differentiation and
leads to ectopic expression of osteoblast-specific
genes in locations where nasal cartilages normally form
(Mori-Akiyama et al., 2003), suggesting that the progen-
itor cells have differentiated into osteoblasts instead of
chondrocytes in the absence of Sox9. Conversely, cul-
tured Runx2−/− calvarial cells differentiate into chondro-
cytes in vitro when treated with Bmp2 (Kobayashi et al.,
2000). In addition, in the mouse embryo with inacti-
vated Osterix (Osx), which encodes for an osteoblast-
specific transcription factor and acts downstream of
Runx2, ectopic chondrocytes form at the expense of
osteoblasts in the bone collar and some areas where
intramembranous bone (e.g., the mandible) should form
(Nakashima et al., 2002). These studies indicate that
cell fate at early differentiation stage is still not fixed
and that the Runx2-expressing early osteoblasts main-
tain some cell fate plasticity and require Osx to ensure
full differentiation along the osteoblast lineage. Further-
more, Sox9, Runx2, and Osx are intrinsic factors not
only required for the determination of one cell type, but
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leading to another cell fate. Consistent with this, ex- v
pression of Runx2 in an osteochondral progenitor cell W
line inhibited chondrocyte differentiation (Lengner et r
al., 2005). However, since genetic inactivation of Sox9, d
Runx2, or Osx primarily leads to loss of one cell type e
without global conversion to another cell type, these f
transcription factors can not be the most upstream e
factors that control chondrocyte and osteoblast differ- t
entiation. Extrinsic factors from the environment may c
act upstream in determining the formation of one cell t
type versus the other by regulating the expression and f
relative levels of these intrinsic factors in the os- W
teochondral progenitor cells. b
Cell-cell signaling between the mesenchymal con- e
densation and its surrounding tissues and/or among e
cells within the condensation plays critical roles in p
osteoblast or chondrocyte differentiation. Expression s
patterns of many Wnts during skeletal development d
suggest that they may signal to the mesenchymal con- s
densations and regulate osteoblast and chondrocyte u
differentiation (Guo et al., 2004; Kato et al., 2002; Parr p
et al., 1993). The canonical Wnt signaling pathway is e
transduced through stabilizing β-catenin protein by in- t
hibiting GSK-3-mediated β-catenin phosphorylation d
(reviewed by Logan and Nusse, 2004). Unphosphory- l
lated β-catenin accumulates in the cytoplasm and m
translocates to the nucleus, where it activates down- o
stream gene transcription by binding to LEF/TCF tran- l
scription factors, whereas phosphorylated β-catenin is s
rapidly degraded. Therefore, the canonical Wnt signal- t
ing activity can be manipulated both in embryonic de- β
velopment and in disease conditions by altering protein d
levels of β-catenin, an obligatory and nonredundant 1
component in transducing the canonical Wnt signaling p
(Guo et al., 2004; Barrow et al., 2003; Huelsken et al., i
2001; Gat et al., 1998). 2
The canonical Wnt signaling activity inhibits chondro- c
cyte differentiation and promotes bone formation (Guo t
et al., 2004; Boyden et al., 2002; Gong et al., 2001). o
However, it was previously unknown whether it was u
also required to determine osteogenic or chondrogenic f
properties of mesenchymal condensations during early w
skeletal development. Here, we found that the canoni- (
cal Wnt signaling activity was upregulated in osteoge- i
nic mesenchymal condensations. Ectopic canonical
d
Wnt signaling enhanced osteoblast differentiation. In
t
addition, conditional ablation of b-catenin in mes-
oenchymal condensations led to loss of osteoblasts and
pectopic chondrocyte differentiation in both intramem-
branous and endochondral ossification. b-catenin may
Walso act non-cell-autonomously outside of the cartilage
ato regulate chondrocyte maturation. Our results indi-
Tcate that Wnt/β-catenin signaling controls osteoblast
oand chondrocyte formation when they differentiate
tfrom mesenchymal progenitors regardless of the origi-
dnal lineage or regional identities of the mesenchymal
2progenitors.
i
CResults
h
βThe Canonical Wnt Signaling Activity Is Upregulated
tin the Forming Osteoblasts
HWe have shown previously that several Wnts are ex-pressed around the mesenchymal condensation duringong bone development (Guo et al., 2004). In the de-
eloping calvarium, some Wnts such as Wnt6, Wnt1,
nt3a, Wnt7a, and Wnt7b are expressed in the sur-
ounding tissues such as the surface ectoderm and the
orsal neural ectoderm that contact the calvarium (Parr
t al., 1993). Moreover, Wnt1, Wnt4, and Wnt14 are
ound to be expressed in the early calvarial cells (Kato
t al., 2002). All these Wnts can, in principle, signal to
he osteochondral progenitor cells through the canoni-
al pathway to regulate β-catenin protein levels. To test
his, we first examined the levels of β-catenin in dif-
erentiating osteochondral mesenchymal progenitors.
e chose the embryonic calvarium (i.e., the frontal
one) and the long bone in the limb to represent a skel-
tal element developing through intramembranous or
ndochondral ossification, respectively. At 13.5 days
ostcoitum (dpc), expression of two early osteoblast-
pecific transcription factors Runx2 and Osx were not
etected in the developing frontal bone (data not
hown) where β-catenin protein levels were already
pregulated (Figures 1A–1C), indicating that β-catenin
rotein upregulation precedes early osteoblast differ-
ntiation in the mesenchymal condensation during in-
ramembranous ossification. In contrast, during en-
ochondral ossification in the limb, β-catenin protein
evels were downregulated in chondrogenic mesenchy-
al condensations (Ryu et al., 2002), and higher levels
f β-catenin protein were found only outside of carti-
age before 13.5 dpc (Guo et al., 2004 and data not
hown) and more specifically in perichondrium/perios-
eum at 15.5 dpc (Figures 1D–1F). Nuclear localized
-catenin was found in differentiating osteoblasts in the
eveloping frontal bone or periosteum (Figures 1B, 1C,
E, and 1F). We then tested whether increased β-catenin
rotein levels led to activation of canonical Wnt signal-
ng, using the TOPGAL mouse embryos (Topol et al.,
003), in which LacZ expression is under the control of
anonical Wnt signaling. LacZ activity was detected in
he mesenchymal progenitor cells, which will become
steoblasts in the forming frontal bone at 12.5 dpc (Fig-
re 1G). In addition, a few LacZ-expressing cells were
ound in the joint and early perichondrium where cells
ill differentiate into osteoblasts in the ulna at 12.5 dpc
Figure 1H). Few LacZ-expressing cells were detected
n early differentiated chondrocytes (Figure 1H). These
ata indicate that β-catenin protein levels as well as its
ranscription activity are selectively upregulated in the
steoblast precursors, likely by the canonical Wnt
athway.
nt Signaling Promotes Osteoblast Differentiation
nd Chondrocyte Hypertrophy
o test whether the canonical Wnt signaling promotes
steoblast differentiation, Wnt14, which is expressed in
he surrounding tissue of the early mesenchymal con-
ensation and differentiating osteoblasts (Guo et al.,
004; Kato et al., 2002), was ectopically expressed dur-
ng endochondral ossification under the control of
ol2a1 promoter and enhancer (Yang et al., 2003). We
ave previously shown that Wnt14 signals through the
-catenin-mediated canonical Wnt pathway in vivo in
he Col2a1-Wnt14 transgenic mice (Guo et al., 2004).
igher levels of Wnt14 expression severely blockedchondrocyte differentiation and subsequent endochon-
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741Figure 1. The Canonical Wnt Signaling Activity Is Upregulated in Differentiating Osteoblasts
(A–F) Fluorescent immunohistochemistry with an anti-β-catenin antibody (green). The nucleus was stained blue by DAPI.
(A) Section of the calvarium at 13.5 dpc. β-catenin protein levels were upregulated in the developing frontal bone (between the arrows).
(B and C) The boxed region in (A) is enlarged, showing β-catenin nuclear localization (arrows).
(D) Section of the tibia at 16.5 dpc. β-catenin protein levels were upregulated in the periosteum (between the arrows).
(E and F) The boxed region in (D) is enlarged, showing β-catenin nuclear localization (arrows).
(G) LacZ expression (arrow) in the frontal bone primordium of the TOPGAL embryo at 12.5 dpc.
(H) LacZ expression in the perichondrium (arrow) of the developing ulna and the forming joint (arrowhead) between the ulna and the humerus
in the TOPGAL embryo at 12.5 dpc. P, proliferative chondrocyte; PH, prehypertrophic chondrocytes; H, hypertrophic chondrocytes.dral bone formation. When Wnt14 was expressed at
lower levels, chondrocyte differentiation was not inhib-
ited in most places, which allowed analysis of the ef-
fects of Wnt/β-catenin signaling on endochondral bone
formation. We found that the expression of Lef1, a di-
rect transcription target of Wnt/β-catenin signaling (Ho-
vanes et al., 2001), was upregulated in the Col2a1-
Wnt14 transgenic mice in places where Wnt14 was
ectopically expressed (Figures 2A# and 2B#), confirming
that the canonical Wnt signaling was indeed activated
by Wnt14. Ossification was enhanced by Wnt14 ectopic
expression indicated by expanded domains of Von
Kossa staining (Figure 2C#) and expression of osteo-
blast markers such as Runx2, Osx, and Osteocalcin
(Figures 2D#–2F#). However, unlike Lef1, Runx2 expres-
sion was not activated where Wnt14 was ectopically
expressed (comparing Figures 2A# and 2B# with 2D#),
suggesting that Runx2 is not an immediate early tran-
scription target of Wnt/β-catenin signaling. Consistent
with expanded osteogenic zone in the Col2a1-Wnt14
embryo, progression of chondrocyte maturation was
accelerated. We examined the expression of Indian
Hedgehog (Ihh) and ColX, markers for prehypertrophic
and hypertrophic chondrocytes, respectively. The re-
gions between the two Ihh or ColX expression domains
in the developing long bones were expanded, although
the entire skeletal size was shorter in the Col2a1-Wnt14
embryo (Figures 2G# and 2I#). Chondrocyte hypertrophy
is followed by extracellular matrix (ECM) remodeling,
blood vessel invasion, and osteoblast migration duringendochondral ossification, in which two major matrix
metalloproteinase (MMP) family members, MMP9 and
MMP13, play critical roles (Stickens et al., 2004; Vu et
al., 1998). MMP9 is expressed in osteoclasts, chon-
droclasts, and endothelial cells, whereas MMP13 is ex-
pressed in terminal hypertrophic chondrocytes and in
the newly recruited osteoblasts. The expression do-
mains of MMP9 and MMP13 were significantly ex-
panded (Figures 2J# and 2K#), demonstrating that the
final maturation of chondrocytes was accelerated by
Wnt14 ectopic expression. These results indicate that
Wnt/β-catenin signaling is sufficient to inhibit chondro-
cyte differentiation, enhance endochondral bone for-
mation, and promote chondrocyte maturation.
Conditional Inactivation of b-catenin Disrupted
Normal Skeletal Development
We have previously shown that inactivation of b-catenin
in micromass cultures leads to greatly enhanced chon-
drocyte differentiation (Guo et al., 2004). In addition,
weakened canonical Wnt signaling results in reduced
bone density (Gong et al., 2001; Kato et al., 2002). Be-
cause components transducing the canonical Wnt sig-
naling upstream of β-catenin such as Frizzled, LRP5/6,
and Dishevelled (Dsh) all exhibit large degrees of func-
tional redundancy in mammalian cells, to further test
whether Wnt/β-catenin signaling plays a decisive role
in chondrocyte and osteoblast differentiation, we inac-
tivated an obligatory and nonredundant component of
the canonical Wnt signaling, β-catenin, during both in-
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Gene expression was analyzed by in situ hybridization with indicated probes on consecutive sections of the developing humerus at 15.5 dpc.
Bone formation was also examined by Von Kossa staining (dark brown). Altered gene expression is indicated by arrows. Osteogenic regions
are indicated by double arrow headed lines.tramembranous and endochondral ossification. The C
ab-catenin conditional mouse Catnbyc/c (Guo et al.,
2004) was crossed with the Dermo1-Cre mouse, in c
twhich Cre activity is detected in early mesenchymal
condensations in the limb bud before chondrocyte and 3
posteoblast differentiation (Yu et al., 2003). Dermo-1
(twist-2) expression was also detected in the early cal- t
mvarial mesenchyme of the developing frontal bone at
12.5 dpc and 13.5 dpc (Li et al., 1995) prior to Runx2 d
eexpression. In addition, we found that after crossing
with the ROSA26 Cre reporter (R26R) mouse (Soriano, e
b1999), LacZ-expressing cells, which indicate the Cre
activity, were found in the forming frontal bone of the t
lDermo1-Cre; R26R embryo (Figure 3A). Therefore, in
the Catnbyc/c;Dermo1-Cre mice, b-catenin was inacti- t
qvated in the mesenchymal progenitor cells, giving rise
to both osteoblasts and chondrocytes regardless of the s
tmechanism of ossification. We found that apart from
synovial joint fusions (Guo et al., 2004), another striking
feature of the Catnbyc/c;Dermo1-Cre embryos was the
abnormal differentiation of osteoblasts and chondro- E
ocytes (Figures 3D, 3E, 3L, and 3M). Ectopic cartilage
formation was observed in the developing calvarium T
ewhere bone formed through intramembranous ossifica-
tion in the Catnbyc/+;Dermo1-Cre control embryos (Fig- C
fures 3F–3I, 3N, and 3O). The long bones were greatly
shortened, thickened, and bowed, and ectopic carti- d
vlage formation was also observed in the Catnbyc/c;
Dermo1-Cre embryos (Figures 3E, 3M, and 3S). In con- c
btrast, ossification was greatly diminished during both
endochondral and intramembranous bone formation 4
D(Figures 3E and 3M). To rule out the possibility that the
skeletal defects in the Catnbyc/c;Dermo1-Cre embryo s
fresulted from abnormal development of the surround-
ing nonskeletal tissues, we also generated the Catnbyc/ s
i−;Col2a1-Cre embryos (Figure 3K) in which Cre expres-
sion was later in the mesenchymal condensation and d
fconfined to chondrocytes (Ovchinnikov et al., 2000).
However, consistent with previous findings in another Col2a1-Cre line (Long et al., 2004), we found that Cre
ctivity in this Col2a1-Cre line was not only detected in
hondrocytes, but also in part of perichondrium/perios-
eum where osteoblasts normally differentiate (Figures
B and 3C). This indicates that the early Col2a1-ex-
ressing chondrogenic cells still retain the competence
o differentiate as osteoblasts and the Col2a1-Cre
ouse allowed us to remove β-catenin activity in chon-
rocytes and some osteoblast precursors during
ndochondral ossification. The Catnbyc/−;Col2a1-Cre
mbryos were perinatal lethal with normal intramem-
ranous ossification (Figure 3K), but they showed ec-
opic cartilage formation in short, thick, and bowed
ong bones (Figures 3K and 3Q). These results indicate
hat β-catenin-mediated canonical Wnt pathway is re-
uired for early intramembranous and endochondral
keletal development by promoting osteoblast differen-
iation while inhibiting chondrocyte formation.
ctopic Chondrocyte Differentiation at the Expense
f Osteoblasts when b-catenin Is Inactivated
o characterize the chondrocyte and osteoblast differ-
ntiation defects in the Catnbyc/c;Dermo1-Cre and
atnbyc/−;Col2a1-Cre embryos in more detail, we per-
ormed Von Kossa and Safranin O staining. Ossification
etected by Von Kossa staining was present in the de-
eloping frontal bone of the Catnbyc/+;Dermo1-Cre
ontrol embryo but absent in the same region in Catn-
yc/c;Dermo1-Cre mutant embryo at 15.5 dpc (Figures
IA and 4IA#). Very interestingly, in the Catnbyc/c;
ermo1-Cre embryo, large patches of chondrocyte-
pecific Safranin O-stained cells (red) were found in the
rontal bone (Figure 4IB#), where intramembranous os-
ification occurred and no chondrocyte-specific stain-
ng was detected in the control (Figure 4IB). The chon-
rocyte identity of these Safranin O-stained cells was
urther confirmed by immunohistochemistry with anti-
olII antibodies (Figure 4IC#). Ectopic chondrocyte dif-
β-Catenin Controls Bone and Cartilage Formation
743Figure 3. Inactivation of b-catenin during
Both Intramembranous and Endochondral
Ossification Led to Ectopic Cartilage Forma-
tion at the Expense of Bone Formation
(A) LacZ expression in the developing frontal
bone (arrow) at 14.5 dpc in the Dermo1-
Cre;R26R mouse.
(B) LacZ expression in both chondrocytes
and perichondrium of a tibia in the Col2a1-
Cre;R26R mouse embryo at 15.5 dpc.
(C) The boxed region in (B) is enlarged,
showing LacZ-expressing cells (arrows) in
both periosteum and primary spongiosa.
(D–S) Skeletal preparations of mouse em-
bryos. Cartilage was stained by Alcian blue
whereas bone was stained by Alizarin red.
Loss of bone formation and ectopic cartilage
formation are indicated by arrows. F, frontal
bone; P, parietal bone; Mx, maxilla; Mn, man-
dible.
(D) Catnbyc/+;Dermo1-Cre embryo at 15.5
dpc.
(E) Catnbyc/c;Dermo1-Cre embryo (littermate
of [D]).
(F) Enlarged head region of (D).
(G) Enlarged head region of (E).
(H) Enlarged head region of (D), dorsal view.
(I) Enlarged head region of (E), dorsal view.
(J) Catnbyc/+;Col2a1-Cre embryo at 17.5 dpc.
A forelimb is shown in (P).
(K) Catnbyc/−;Col2a1-Cre embryo (littermate
of [J]). A forelimb is shown in (Q).
(L) Catnbyc/+;Dermo1-Cre mouse embryo at
17.5 dpc. The dorsal view of the head is
shown in (N) and a forelimb is shown in (R).
(M) Catnbyc/c;Dermo1-Cre embryo (littermate
of [L]). The dorsal view of the head is shown
in (O) and a forelimb is shown in (S).ferentiation was also found in the developing long
bones in Catnbyc/c;Dermo1-Cre and Catnbyc/−;Col2a1-
Cre embryos (Figures 4II and 4III). In both of these
conditional mutant embryos, according to chondro-
cyte-specific Safranin O-staining and cell morphology,
ectopic chondrocytes formed in a wedge-shaped re-
gion in the places where osteoblast differentiation and
invasion normally occurred in the Catnbyc/+;Dermo1-
Cre and Catnbyc/+;Col2a1-Cre control embryos (Fig-
ures 4IIA, 4IIA#, 4IIB, 4IIB#, 4IIIA, 4IIIA#, 4IIIB, and
4IIIB#). Ectopic chondrocyte differentiation was accom-
panied by greatly diminished ossification as compared
to the control (Figures 4IIC, 4IIC#, 4IID, 4IID#, 4IIIC,
4IIIC#, 4IIID, and 4IIID#). As a result, the hypertrophic
chondrocyte region was expanded in both Catnbyc/c;
Dermo1-Cre and Catnbyc/−;Col2a1-Cre embryos (Fig-
ures 4IIA# and 4IIIA#). The residual bone formation in
the Catnbyc/c;Dermo1-Cre embryos is likely due to in-
complete inactivation of b-catenin (Supplemental Fig-
ure S1 available with this article online), and more com-
plete b-catenin inactivation in the Catnbyc/−;Dermo1-
Cre embryo leads to embryonic lethality before 11.5
dpc. All these data indicate that β-catenin signaling is
required for suppressing chondrocyte differentiation
and allowing osteoblasts to form during both intra-
membranous and endochondral ossification.Ectopic Chondrocyte Formation at the Expense
of Osteoblast Differentiation Occurred
at an Early Differentiation Stage
To further investigate the differentiation stage when os-
teoblast and chondrocyte formation was altered in both
Catnbyc/c;Dermo1-Cre and Catnbyc/−;Col2a1-Cre em-
bryos, we examined by in situ hybridization the expres-
sion of chondrocyte- and osteoblast-specific genes
that are activated at early differentiation stages (Figures
5 and 6 and Supplemental Figure S2). Corresponding
to loss of ossification and ectopic chondrocyte differ-
entiation in the frontal bone in the Catnbyc/c;Dermo1-
Cre embryos at 15.5 dpc (Figure 5A#), an early chondro-
cyte-specific marker Sox9 was ectopically expressed
(Figure 5B#), whereas the expression of an early osteo-
blast marker ColI was dramatically reduced or com-
pletely missing where ectopic chondrocytes formed
(Figure 5C#). In addition, the expression of transcription
factors required for early osteoblast differentiation,
Runx2 and Osx, was not detected (Figures 5D# and
5E#). As a result, the expression of Osteocalcin, a
marker for mature osteoblasts, was also missing in the
mutant frontal bone (Figure 5F#).
When similar analysis was done in the developing
long bones in both Catnbyc/−;Col2a1-Cre and Catnbyc/c;
Dermo1-Cre embryos, we found that in the wedge-
Developmental Cell
744Figure 4. Histological Analysis of Intramembranous and Endochondral Ossification
(I) Analyses of intramembranous ossification in consecutive sections of the developing frontal bone at 15.5 dpc. Ossified region is indicated
by arrows and ectopic cartilage formation is indicated by arrowheads.
(A and A#) Von Kossa staining.
(B and B#) Safranin O staining (red).
(C and C#) ColII immunohistochemistry (red). Nucleus was stained by DAPI (blue).
(II and III) Analyses of endochondral ossification in consecutive sections of the developing humerus at 17.5 dpc.
(IIA, IIA#, IIIA, and IIIA#) Safranin O staining. The hypertrophic chondrocyte regions are indicated by yellow lines.
(IIB, IIB#, IIIB, and IIIB#) The boxed regions are enlarged.
(IIC, IIC#, IIIC, and IIIC#) Von Kossa staining.
(IID, IID#, IIID, and IIID#) The boxed regions are enlarged. Ossification is indicated by arrows, whereas wedge-shaped ectopic cartilage is
indicated by arrowheads.shaped region where Safranin O-stained cells were a
ifound, chondrocyte markers Sox9 and ColII were
strongly expressed at 17.5 dpc (Figures 6A# and 6B# m
rand Supplemental Figure S2). This phenotype has been
similarly observed in the Osx mutant mice in which os-
bteoblast differentiation is completely blocked (Naka-
shima et al., 2002). Corresponding to the ectopic ex- d
apression of chondrocyte markers, periosteum was
much thinner and expression of osteoblast markers C
psuch as ColI, Runx2, Osx, and Osteocalcin were greatly
diminished (Figures 6E#–6H# and Supplemental Figure p
tS2). Interestingly, ectopically differentiated chondro-
cytes in the long bones also underwent hypertrophy, as C
bexpression of Ihh and ColX were both detected in the
ectopic cartilage in the presumed bone region in both s
dCatnbyc/−;Col2a1-Cre and Catnbyc/c;Dermo1-Cre em-
bryos (Figures 6C# and 6D# and Supplemental Figure p
eS2). Taken together, inactivation of b-catenin leads to a
change in early differentiation of mesenchymal progeni- n
mtors from that leading to osteoblasts to the one that
leads to chondrocytes during both intramembranous bnd endochondral ossification. Wnt/β-catenin signaling
s upstream to the expression of the important bone
atrix protein ColI and two early transcription factors
equired for osteoblast differentiation, Runx2 and Osx.
We have also examined chondrocyte maturation and
lood vessel invasion, as they are required for en-
ochondral ossification in the developing long bone
nd found that both processes were delayed in Catnbyc/−;
ol2a1-Cre and Catnbyc/c;Dermo1-Cre embryos (Sup-
lemental Figures S3 and S4). These changes were op-
osite to what was observed in the Col2a1-Wnt14
ransgenic mice, indicating that the phenotypes in both
atnbyc/−;Col2a1-Cre and Catnbyc/c;Dermo1-Cre em-
ryos resulted from inactivation of the canonical Wnt
ignaling. Last, we examined cell proliferation and cell
eath in the developing calvarium and long bone (Sup-
lemental Figure S5). The slight changes in cell prolif-
ration and apoptosis indicate that Wnt/β-catenin sig-
aling also supports proliferation and survival of
esenchymal progenitor cells during both intramem-
ranous and endochondral ossification.
β-Catenin Controls Bone and Cartilage Formation
745Figure 5. Analyses of Early Chondrocyte and
Osteoblast Gene Expression during Intra-
membranous Ossification
Consecutive sagittal sections of the de-
veloping frontal bone at 15.5 dpc were ex-
amined by Von Kossa staining and in situ hy-
bridization with indicated 35S-labeled ribo-
probes. Ectopic cartilage formation is indi-
cated by arrows.fundamental role in osteoblast and chondrocyte forma- rus (Guo et al., 2004) to inactivate b-catenin. It has been
Figure 6. Analyses of Early Chondrocyte and Osteoblast Gene Expression during Endochondral Ossification
Consecutive sections of the developing humerus at 17.5 dpc were examined by in situ hybridization with indicated 35S-labeled ribo-probes.
The ectopic wedge-shaped cartilage region is indicated by arrows. The hypertrophic chondrocyte region is indicated by double arrow headed
lines. The periosteum is indicated by arrowheads in the mutant.-Catenin Signaling Is Required for Proper
Osteoblast and Chondrocyte Differentiation
of Mesenchymal Progenitor Cells
To further test whether Wnt/β-catenin signaling plays ation when mesenchymal progenitor/stem cells are dif-
ferentiating, we cultured the mesenchymal progenitor
cells from the developing calvarium of the Catnbyc/c
mouse embryos at 12.5 dpc and used the Cre-adenovi-
Developmental Cell
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sgenitor cells can mimic intramembranous ossification
and differentiate into osteoblasts under proosteogenic u
bconditions (Marvaso and Bernard, 1977). We used Von
Kossa and subsequent Alcian blue staining to distin- T
aguish bone from cartilage nodules, respectively. While
the Catnbyc/c cells formed large, flat bone nodules that n
Cwere dark brown after Von Kossa staining (Figure 7IA),
Catnbyc/c cells after Cre-adenovirus infection formed t
asmall cartilage nodules like those in micromass cul-
tures, which were not stained by the Von Kossa meth- s
mods (Figure 7IA#), but they were stained dark blue byFigure 7. The Canonical Wnt Signaling Is Re-
quired for Osteoblast versus Chondrocyte
Formation when Mesenchymal Progenitor
Cells Differentiate
(I) Mesenchymal progenitor cells isolated
from the developing calvarium of mouse em-
bryos at 12.5 dpc were cultured in vitro un-
der osteogenic conditions.
(A and A#) Von Kossa staining of cell cultures
(dark brown).
(B and B#) The same cultures were stained
with Alcian blue after Von Kossa staining.
(C and C#) 5 m sections of the bone nod-
ules in (B) or cartilage nodules in (B#) were
counterstained by Nuclear fast red. The
bone matrix was dark brown (arrow in [C])
and chondrocytes were dark blue (arrow in
[C#]).
(II) Proposed model for the molecular mech-
anism underlying formation of osteoblasts
versus chondrocytes and the distinction be-
tween intramembranous and endochondral
ossification. Mesenchymal progenitor cells
are shown in light red. Osteoblasts are
shown in red and bigger in size. Chondro-
cytes are shown in light blue. Dual potential
mesenchymal progenitors express both
Sox9 and Runx2. Sox9 expression is much
weaker in osteogenic condensations. The
canonical Wnt signaling inhibits chondrocyte
differentiation and only allows osteoblasts to
form during intramembranous ossification by
inhibiting Sox9 expression, but promoting
Runx2 expression. During endochondral os-
sification, the canonical Wnt signaling is
inhibited such that Sox9 expression is
upregulated and Runx2 expression is down-
regulated. In this case, chondrocyte differen-
tiation occurs first to form the cartilage.
Later, Runx2 expression is upregulated in the
perichondrium by the canonical Wnt signal-
ing to form endochondral bone.lcian blue (Figure 7IB#). We noticed that there were
mall groups of cells in the center of the cartilage nod-
les in the Catnbyc/c; Cre-adenovirus culture that were
igger in size and stained by the Von Kossa method.
hese cells were hypertrophic chondrocytes. To further
nalyze the morphology and cellular content of the
odules formed in cultures of Catnbyc/c and Catnbyc/c;
re-adenovirus cells, the nodules were sectioned and
he sections were stained by nuclear red (Figures 7IC
nd 7IC#). We confirmed that only osteoblasts, which
ecreted bone matrix stained by the Von Kossa
ethod, differentiated in the Catnbyc/c culture whereas
β-Catenin Controls Bone and Cartilage Formation
747in the b-catenin-inactivated Catnbyc/c culture, only Al-
cian blue-stained chondrocytes were detected (Figures
7IC and 7IC#). Despite the dramatic change in cell dif-
ferentiation, we did not detect difference in cell prolifer-
ation and survival between the cultured Catnbyc/c and
Catnbyc/c;Cre-adenovirus calvarial cells at different
time points (Supplemental Figure S7). These results de-
monstrate that β-catenin signaling is required to inhibit
chondrocyte differentiation and allow osteoblasts to
form from embryonic mesenchymal progenitor cells.
Discussion
We have shown here that the Wnt/β-catenin signaling
in mesenchymal progenitor cells plays an essential role
in controlling osteoblast and chondrocyte differentia-
tion. Ectopic Wnt/β-catenin signaling inhibits chondro-
cyte differentiation and promotes ossification. Con-
versely, when β-catenin is genetically inactivated in the
mesenchymal progenitor cells, osteoblast differentia-
tion is replaced by ectopic chondrocyte formation re-
gardless of the regional location or the ossification
mechanism, whether it is through intramembranous or
endochondral ossification.
Strength of the Wnt/-Catenin Signaling Controls
Osteoblast and Chondrocyte Differentiation
As inhibition of GSK-3-mediated β-catenin phosphory-
lation is an essential step in transducing the canonical
Wnt signaling through stabilizing β-catenin, other sig-
naling pathways that regulate GSK-3 may potentially
modulate β-catenin protein levels. Activation of the ser-
ine-threonine protein kinase Akt or integrin linked ki-
nase (ILK) has been shown to upregulate β-catenin pro-
tein levels by inhibiting GSK-3 through phosphorylation
in vitro. However, skeletal defects in ILK- or AKT-defi-
cient mice indicate that their in vivo functions in the
developing skeletal system is to primarily transduce the
β1-integrin or IGF signaling, respectively (Sakai et al.,
2003; Terpstra et al., 2003; Peng et al., 2003; Aszodi et
al., 2003; Liu et al., 1993). The skeletal defects in the
β-catenin-deficient mouse described here and in an-
other study are different from those in the ILK- or AKT-
deficient mouse (Akiyama et al., 2002). In addition, we
found that unlike β-catenin, which is downregulated in
chondrocytes, high levels of activated AKT were de-
tected in chondrocytes, and β-catenin upregulation
preceded AKT activation in the perichondrium at 15.5
dpc (T.F.D. and Y.Y., unpublished data). Because multi-
functional kinases such as GSK-3 are present, together
with their substrates such as β-catenin, in distinct com-
plexes that are independently regulated by different
stimuli such as Wnt, insulin, and hedgehog (Zhang et
al., 2005; Price and Kalderon, 2002; Jia et al., 2002;
Frame and Cohen, 2001), it wouldn’t be surprising that
β-catenin is regulated by the GSK-3 that is not primarily
regulated by AKT or ILK during chondrocyte and osteo-
blast differentiation. Indeed, we found that inhibiting
Phosphatidylinositol 3-kinase (PI3K), which activates
ILK and AKT, by treating mesenchymal progenitor
cell cultures with different doses of a PI3K inhibitor
Ly294002 led to suppression of both osteoblast and
chondrocyte differentiation as reported before (Fujita etal., 2004 and data not shown). These observations indi-
cate that β-catenin protein levels in early mesenchymal
condensations are not regulated primarily by AKT or
ILK signaling, but rather, they are likely to be primarily
controlled by Wnt signaling since ectopic Wnt14 ex-
pression led to skeletal phenotypes opposite to those
caused by β-catenin inactivation in mouse embryos.
Nevertheless, our data do not rule out the possibility
that Wnt/β-catenin signaling can be modulated by other
signaling pathways through different mechanisms.
Both intramembranous and endochondral ossifica-
tion starts from mesenchymal condensations, but the
outcomes are distinct: mesenchymal progenitor cells
only differentiate into osteoblasts during intramem-
branous ossification, whereas during endochondral os-
sification, both chondrocytes and osteoblasts form and
chondrocyte differentiation precedes endochondral
bone formation (de Crombrugghe et al., 2001). Two re-
lated issues fundamental to our understanding of skel-
etal development remain unresolved. The first is the
molecular and cellular events that cause intramembra-
nous versus endochondral ossification. The second is
the molecular mechanism underlying cell fate determi-
nation between chondrocytes and osteoblasts. We
have shown previously that Wnt/β-catenin signaling in-
hibits chondrocytes differentiation (Guo et al., 2004). By
showing here that mesenchymal progenitor cells form
chondrocytes instead of osteoblasts during both en-
dochondral and intramembranous ossification when
b-catenin is inactivated, we conclude that the initial os-
teoblast or chondrocyte differentiation is linked to
specification of intramembranous or endochondral os-
sification by a common molecular regulator that re-
quires the Wnt/β-catenin signaling (Figure 7II). It is likely
that upregulation of β-catenin protein levels, most likely
by Wnt signaling, is enough to inhibit Sox9 expression
while promoting Runx2 expression, leading to osteo-
blast but not chondrocyte differentiation inside the in-
tramembranous condensation. On the other hand,
β-catenin protein level is kept low by inhibiting the ca-
nonical Wnt signaling inside mesenchymal condensa-
tions during endochondral bone formation, such that at
first only chondrocytes can form and osteoblasts dif-
ferentiate later in the periphery where Wnt signaling is
upregulated. This is supported by observations that
several Wnts are expressed at the periphery of the
newly formed cartilage in the limb (Guo et al., 2004),
while some Wnt antagonists, including Sfrp2 and Sfrp3,
are expressed within the chondrogenic mesenchymal
condensation (Hoang et al., 1998; Lescher et al., 1998).
In addition, it has been shown that Sox9 promotes the
degradation of β-catenin (Akiyama et al., 2004). Thus,
restricting high-level expression of Sox9 to only chon-
drogenic condensations may be a critical step in both
intramembranous and endochondral ossification. This
step appears to be regulated by the Wnt/β-catenin sig-
naling pathway, as ectopic Sox9 expression was found
in ectopic chondrocytes in the developing calvarium
and long bones when b-catenin was inactivated. The
mutual inhibition between Sox9 expression and the ca-
nonical Wnt signaling indicates that chondrocyte differ-
entiation is controlled by a positive feedback loop in
which initial inhibition of the canonical Wnt signaling
leads to Sox9 expression, which further inhibits Wnt
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ddifferentiation of chondrocytes. Likewise, osteoblast
differentiation may also be controlled by a positive t
cfeedback loop in which activation of the canonical Wnt
signaling leads to inhibition of Sox9 expression and ini- c
ntial osteoblast differentiation (as shown by the expres-
sion of ColI), and these early osteoblasts then express a
mother factors including more Wnts, LRP5 (Kato et al.,
2002), Runx2, and Osx to enhance the osteoblast differ-
entiation program. Consistent with this, ectopic chon- S
Mdrocyte differentiation is observed in Osx−/− embryos
(Nakashima et al., 2002), which might be a result of W
Odownregulation of Wnt/β-catenin signaling when osteo-
blast differentiation failed to proceed. In this regard, the d
cpreviously observed mutual suppression between the
genetic programs leading to chondrocyte or osteoblast t
rdifferentiation inside common osteochondral progeni-
tors may be mediated by the Wnt/β-catenin signaling. r
iThus, the strength of the Wnt/β-catenin signaling is an
early determinant that may differentially regulate chon- c
(drocyte versus osteoblast differentiation and determine
whether intramembranous or endochondral ossification s
dwill occur. The difference in the canonical Wnt signaling
activity in the mesenchymal condensations during in- i
atramembranous and endochondral ossification may be
controlled by more upstream events, which may also W
odictate other intrinsic differences between the two
types of ossification mechanism. m
vPreviously, we have shown that the canonical Wnt
signaling induced early steps of joint formation (Guo et p
cal., 2004). In contrast to Runx2 and Osx, early joint
markers such as Gdf5 and ColI appeared to be direct n
dtranscriptional targets of the canonical Wnt signaling. It
is possible that Wnt signaling suppresses chondrocyte t
differentiation and plays a direct role in synovial joint
Einduction. Later, Wnt signaling together with other sig-
naling pathways, which may also be induced by Wnt L
signaling, promotes osteoblast differentiation. Consis- a
tent with this, we have found that apart from Gdf5, L
(Bmp2 expression was also activated by ectopic ex-
4pression of Wnt14 or an activated form of b-catenin
e(X.G., unpublished observations). Recent in vitro studies
chave shown that canonical Wnt signaling itself is not 3
sufficient, but it can synergize with BMP signaling in e
promoting osteoblast differentiation (Mbalaviele et al., C
L2004).
j
hRelationship of the Canonical Wnt Signaling
L
with Other Signaling Pathways k
Among the many signaling pathways regulating skeletal (
development, the canonical Wnt pathway is unique, as
Sit exerts completely opposite activities in controlling
Edifferentiation of osteoblasts and chondrocytes from
bmesenchymal condensations. Bone morphogenetic pro-
S
teins (BMPs) promote both chondrocyte and osteoblast 1
differentiation (ten Dijke et al., 2003; Yoon and Lyons,
2004). Ihh is required only for endochondral bone for- M
Tmation and is not essential for chondrocyte differentia-
ition from mesenchymal progenitors (Long et al., 2004;
aSt-Jacques et al., 1999). Fibroblast growth factor (Fgf)
a
signaling regulates osteoblast and chondrocyte prolif- s
eration and maturation (Liu et al., 2002; Ohbayashi et d
Fal., 2002; Iseki et al., 1999). However, it is not clearhether it is required for early differentiation of chon-
rocytes or osteoblasts. Nevertheless, it is very likely
hat many signaling pathways interact with the canoni-
al Wnt signaling pathway in controlling osteoblast and
hondrocyte differentiation. Further experiments are
eeded to clarify the genetic epistasis between Wnt
nd other signaling pathways in controlling both intra-
embranous and endochondral bone formation.
elective Chondrocyte or Osteoblast Differentiation
ay Be Achieved by Manipulating the Canonical
nt Signaling Pathway
steoporosis and arthritis are common degenerative
iseases caused by reduced bone mass and loss of
hondrocytes in the joint region, respectively. In addi-
ion, bone and cartilage repair is needed in many inju-
ies. Since both chondrocytes and osteoblasts are de-
ived from common mesenchymal progenitors residing
n early embryonic mesenchymal condensations, peri-
hondrium/periosteum, calvarium, and bone marrow
Jones et al., 2002; Marvaso and Bernard, 1977), under-
tanding the molecular mechanisms whereby cell fate
etermination between chondrocytes and osteoblasts
s controlled is important for studies on tissue repair
nd engineering. Our results suggest that the canonical
nt signaling may act as a molecular switch between
steoblast and chondrocyte cell fates when mesenchy-
al progenitor cells are differentiating in vitro and in
ivo. Therefore, it is possible to direct mesenchymal
rogenitor cell differentiation along either a chondro-
yte or an osteoblast lineage by manipulating the ca-
onical Wnt signaling. This finding will pave the way for
eveloping efficient therapeutic approaches to selec-
ively repair cartilage or bone damage.
xperimental Procedures
acZ Staining, Histology, In Situ Hybridization,
nd Immunohistochemistry
acZ staining of the TOPGAL mice was performed as described
Topol et al., 2003). For in situ hybridizations, embryos were fixed in
% paraformaldehyde at 4°C overnight. Some fixed samples were
mbedded in paraffin and sectioned at 5 m thickness. Histologi-
al analysis, immunohistochemistry, whole-mount, and radioactive
5S RNA in situ hybridization were performed as described (Yang
t al., 2003). The primary antibodies used were anti-ColII (Santa
ruz) at 1:200 and monoclonal anti-β-catenin (Transduction
aboratories) at 1:50. Signals were detected using Alexa Fluor-con-
ugated secondary antibodies (Molecular Probes). Probes for in situ
ybridization have been described previously: ColX, ColII, ColI,
ef1, Wnt14, Runx2, and Osteocalcin (Guo et al., 2004); Osx (Na-
ashima et al., 2002); Sox9 (Topol et al., 2003); and Ihh and Ptc
Yang et al., 2003).
keletal Analysis
mbryos at 15.5 dpc or 17.5 dpc were dissected in PBS. The em-
ryos were then skinned, eviscerated, and fixed in 95% ethanol.
keletal preparations were performed as described (McLeod,
980).
esenchymal Progenitor Cell Cultures
he developing calvarium between the skin and brain tissues were
solated from the embryonic mouse skull at 12.5 dpc in Hanks Bal-
nced Salt Solution (HBSS, Sigma) and digested in 0.5% collagen-
se, 0.25% dextrose in HBSS at 37°C for 1 hr. The cells were disas-
ociated by repetitive pupating with a 1 ml micropipette, spun
own, resuspended in BGJb medium (Invitrogen) containing 10%
BS, 1× Antibiotics/Antimycotics (Invitrogen), and plated in 12-well
β-Catenin Controls Bone and Cartilage Formation
749plates at 3.5 × 105 cells per well. To infect the cells with the Cre-
adenovirus, the Cre-adenovirus was added to resuspended cells at
5 × 109 pfu, which were then gently rocked at 4°C for 2 hr before
plating. Plated cells were allowed to grow to confluency, and then
induced to differentiate at day 5 by adding β-glycerophosphate
(5 mM) and ascorbic acid (50 g/ml). The cultures were let grow for
3 weeks and then stained according to the Von Kossa method and
then by Alcian blue.
Von Kossa and Alcian Blue Staining
For Von Kossa staining of cell cultures, cells were first fixed in 2.5%
gluteraldehyde in PBS for 2 hr, washed once in distilled water, and
then stained with 5% silver nitrate under a 60 watt lamp for 1 hr.
Cell cultures were washed in distilled water 3 times, then in 5%
sodium thiosulfate for 5 min, and then rinsed in water. For Von
Kossa staining of tissue sections, slides were deparaffinized, rehy-
drated, stained with 5% silver nitrate for 1 hr under a 60 watt lamp,
and rinsed in distilled water. Then slides were soaked in 5% sodium
thiosulfate for 5 min, washed in distilled water, stained with Nuclear
fast red for 5 min, rinsed in distilled water, dehydrated, and cleared
in xylene before mounting with Permont.
For Alcian blue staining, cell cultures were washed three times
with PBS, stained in 1% Alcian blue, 3% acetic acid for 2 hr, and
then washed three times in 3% acetic acid.
Sectioning of Bone/Cartilage Nodules
After Von Kossa and Alcian blue staining, cell cultures with bone or
cartilage nodules were peeled off with forceps, fixed overnight in
4% paraformaldehyde at room temperature, embedded in paraffin,
and sectioned at 5 m thickness. Slides were then counterstained
with Nuclear fast red.
Supplemental Data
Supplemental Data include seven figures and Supplemental Re-
sults and can be found with this article online at http://www.
developmentalcell.com/cgi/content/full/8/5/739/DC1/.
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